"With Wind and Truth out as of a few days ago, it is finally time to move Stormlight to the back burner for a while," Sanderson wrote. "It was a fifteen-year-effort to get this sequence done ...

AbbVie, a drug company based in North Chicago, Illinois, is paying $200 million to acquire Madison-based Nimble Therapeutics, which is developing an oral therapy that could treat psoriasis and ...

The acquisition of Nimble Therapeutics will grant AbbVie access to a pipeline of oral peptide drugs for the treatment of immune diseases including psoriasis and inflammatory bowel disease AbbVie and ...

AbbVie has agreed to acquire Nimble Therapeutics for $200m in cash at closing, subject to standard adjustments, alongside potential interim funding payments. The acquisition includes Nimble's ...

The Nimble acquisition, which follows the $1.4 billion buy of Aliada Therapeutics in October, will help AbbVie rebuild and cement its long-term growth prospects following the Phase II failure of ...

AbbVie has agreed to buy privately held biotechnology company Nimble Therapeutics for $200 million in cash in a deal that bolsters the biopharmaceutical company's expansive immunology portfolio.

North Chicago-based AbbVie announced today that it plans to buy Nimble Therapeutics and its promising drug designed to treat psoriasis and inflammatory bowel disease. Nimble also has a pipeline of ...

Having tried this out via expansion route with Patrick Rothfuss’ The Name of the Wind, this time Call to Adventure series took a step further with a standalone follow-up based, once again, on a very ...